LuciMird

LuciMird uses and dosage

LuciMird (Mirdametinib), generic Gomekli is a prescription medicine used to treat adult and pediatric patients aged 2 years and older with Neurofibromatosis Type 1 (NF1) who have symptomatic plexiform neurofibromas that are not amenable to complete surgical resection. As a MEK inhibitor, mirdametinib targets the dysregulated RAS/MAPK signaling pathway associated with NF1, thereby reducing tumor burden and improving disease-related symptoms, including pain, functional impairment, and disfigurement caused by these tumors. LuciMird manufactured by Lucius Pharma Ltd. In Laos. Mirdametinib has to be take orally twice daily for 21 days of each 28-day cycle, with or without food.

LuciMird side effects

The most common side effects of Mirdametinib are: Rash, Stomach pain, diarrhea, nausea, or vomiting, Muscle, bone, or joint pain, Tiredness, Headache, Skin redness, swelling, or pain around your fingernails or toenails, Heart problems.

Originator brand

Gomekli by SpringWorks Therapeutics, Inc

Made by

Lucius Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.